Filing Flows › Comparisons › CYRX vs CYTK
Cryoport vs Cytokinetics: CYRX and CYTK compared
Cryoport is the larger company: $50.2M of revenue in its latest quarter (Q3 2026) against $47.6M for Cytokinetics (Q3 2026). Cytokinetics is growing faster (25× against +14% a year earlier). Cryoport is more profitable, with an operating margin of -17.5% against -351.3%.
Where the money goes: CYRX and CYTK
Cryoport (CYRX) · Q3 2026
Cryoport, Q3 2026: revenue $50.2M (+14% year over year), operating margin -17.5%, net loss $10.9M, operating cash flow $5.2M. The chart follows the revenue to costs, profit and cash.
Cytokinetics (CYTK) · Q3 2026
Cytokinetics, Q3 2026: revenue $47.6M (25× year over year), operating margin -351.3%, net loss $190M, operating cash flow −$124M. The chart follows the revenue to costs, profit and cash.
| Cryoport (CYRX) | Cytokinetics (CYTK) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $50.2M | $47.6M |
| Revenue growth, Y/Y | +14% | 25× |
| Operating margin | -17.5% | -351.3% |
| Net earnings | −$10.9M | −$190M |
| Net margin | -21.6% | -399.7% |
| Operating cash flow | $5.2M | −$124M |
| Market value | — | $8.4B |
| Analysts’ mean target | — | $107.22 |
Where the revenue comes from
Cryoport
- Service: $28.6M (57%)
- Product: $21.7M (43%)
Cytokinetics
- Net Product Revenue: $44.5M (94%)
- Collaboration Revenues: $3.0M (6%)
Questions
Which is bigger, Cryoport or Cytokinetics?
Cryoport is the larger company: $50.2M of revenue in its latest quarter (Q3 2026) against $47.6M for Cytokinetics (Q3 2026).
Is Cryoport or Cytokinetics growing faster?
Cytokinetics is growing faster (25× against +14% a year earlier).
Which is more profitable, Cryoport or Cytokinetics?
Cryoport is more profitable, with an operating margin of -17.5% against -351.3%.
More: Cryoport earnings · how Cryoport makes money · Cytokinetics earnings · how Cytokinetics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.